Tuesday, March 28, 2017
 
 
Company News: Page (1) of 1 - 03/20/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Rat Model Market Size Worth $845.0 Million by 2025 | CAGR: 8.3%: Grand View Research, Inc.
 
(March 20, 2017)

SAN FRANCISCO, March 20, 2017 /PRNewswire/ --

The global rat model market is expected to reach USD 845.0 million by 2025, according to a new report by Grand View Research, Inc. As of 2016, outbred type of rat model is commonly utilized for research and educational activities within the healthcare domain. However, advancement in production technologies is expected to boost growth of knockout and conditioned rats.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757 )


The production technologies for aforementioned type of model are recent in nature and can be traced back to 2008, post the development of mobile DNA technology. The first knockout model was introduced in 2009 using Zinc Finger Nuclease (ZFN) method, which led to an advancement in the field of rat models. Other tools for genetic editing are Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), homologous recombination, and N-ethyl-N-nitrosourea (ENU) mutagenesis.

Furthermore, supportive infrastructure and technology coupled with growing incidence of chronic conditions & genetic mutation amongst human species are expected to extend higher applicability for research purposes, thereby boosting growth.

Browse full research report with TOC on "Rat Model Market Analysis By Type (Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned), By Technology (Nuclear Transferase, Microinjection), By Application, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/rat-model-market

Further key findings from the report suggest: 

  • Outbred is expected to dominate the type segment for rat model market. Presence of numerous outbred type and higher applicability of these to mimic human diseases is anticipated to support growth over the forecast period.
  • Microinjection is anticipated to witness the fastest growth over the forecast period owing to faster development of the models and reduction in breeding time. Similarly, development of newer technology within the other segment is expected to propel growth.
  • Based on services, the rat model market is predicted to witness higher revenue contribution by breeding process. Cryopreservation is anticipated to witness fastest growth over the forecast period.
  • Rising production of conditioned rats for behavioral studies and growing R&D within neurological application is expected to support lucrative growth of rat model. Other application expected to support growth include cardiovascular disorders, diabetes, obesity, and renal disorders.
  • The key market players of the industry include Covance Inc.; Envigo; Charles River Laboratories International, Inc.; Horizon Discovery Group plc.; TransViragen, Inc.; Javier Labs; and others. Mergers & acquisitions are expected to strengthen company capabilities. For instance, Horizon Discovery Group plc. accomplished the aforementioned goal by acquiring SAGE Labs, Inc. in 2014.

Browse related reports by Grand View Research: 

Grand View Research has segmented the global rat model market on the basis of type, technology, service, application, end-use, and region: 

  • Global Rat Model Type Outlook (Revenue, USD Million, 2014 - 2025) 
    • Knockout
    • Outbred
    • In bred
    • Hybrid
    • Immunodeficient
    • Conditioned
  • Global Rat Model Technology Outlook (Revenue, USD Million, 2014 - 2025) 
    • Nuclear transferase
    • Microinjection
    • Embryonic stem cell
    • Other
  • Global Rat Model Service Outlook (Revenue, USD Million, 2014 - 2025) 
    • Cryopreservation
    • Breeding
    • Re-derivation
    • Genetic testing
    • Quarantine
    • Other
  • Global Rat Model Application Outlook (Revenue, USD Million, 2014 - 2025) 
    • Oncology
    • Neurology
    • Immunology
    • Toxicology
    • Other
  • Global Rat Model End-use Outlook (Revenue, USD Million, 2014 - 2025) 
    • CROs
    • Academic and research institutes
    • Healthcare companies
  • Rat Model Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
    • Latin America
      • Brazil
      • Mexico
    • Middle East and Africa (MEA)
      • South Africa

Read Our Blog: Rat Model Market Outlook: Analyst's Perspective

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com

SOURCE Grand View Research, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA, Inc., Medicine, Diet, healthcare, medical technologists, Surgery, Science, Biology, Genetics, Business, Other,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • More Evidence of the Link Between Gum Disease and Diabetes Points Out the Systemic Importance of Good Oral Health, says Dr. Peiman Soleymani
  • Global $20.99 Billion Ablation Devices Market 2017-2023: Oncology is Holding the Largest Revenue in 2016
  • PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 Programs
  • Cryotherapy and Cryosurgery Market Rises High Incidence Of Cancer - IndustryARC
  • Global Radiology Oncology Surgical Robot Device Markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 - Acute Market Reports

    Cancer
  • COA Completely Disagrees with Draft MedPAC Medicare Part B Recommendations
  • Anpac Bio Surpasses 40,000 Case Study Milestone 'Liquid Biopsy Pioneer' Serving Individual, Medical, Insurance & Corporate Customers
  • iCAD Receives FDA Approval For PowerLook Tomo Detection
  • Varian Medical Systems Schedules Mid-Year Review with Investors
  • Clint Holmes Joins Sapphire Foundation for Prostate Cancer at the 14th Annual Poker and Golf Tournament June 4th and 5th, 2017
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines